CNTO1275

ustekinumab · Centocor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNTO1275, covering 2009-12-02 to 2009-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis [Phase 2]